Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K
Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

579
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
579
Blind Procedures02:07

Blind Procedures

13.9K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

228
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
228

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Individualised progesterone receptor modulator prevention strategies for triple-negative breast cancer in BRCA1 pathogenic variant carriers.

NPJ breast cancer·2026
Same author

Benefit-risk balance of S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC).

The oncologist·2026
Same author

Methods for Evaluation of Surrogate Endpoints for Health Technology Assessment Decision Making: A Good Practices Report of an ISPOR Task Force.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2026
Same author

Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens.

JAMA oncology·2025
Same author

Regional variation in clinical-trial risks: a large-scale analysis of 585 clinical trials.

BMJ open·2025
Same author

Use of surrogate endpoints in health technology assessment and reimbursement of treatments for the management of chronic kidney disease.

EClinicalMedicine·2025
Same journal

Clinical trials involving prisoners: a bioethical perspective.

Clinical investigation·2022
Same journal

Outcome measures in amyotrophic lateral sclerosis clinical trials.

Clinical investigation·2017
Same journal

Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

Clinical investigation·2015
Same journal

Novel oral taxane therapies: recent Phase I results.

Clinical investigation·2015
Same journal

Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease.

Clinical investigation·2015
Same journal

Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence.

Clinical investigation·2015
See all related articles

Related Experiment Video

Updated: Apr 16, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Data fraud in clinical trials.

Stephen L George1, Marc Buyse2

  • 1Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC 27705-3833, USA.

Clinical Investigation
|March 3, 2015
PubMed
Summary
This summary is machine-generated.

Data fraud in clinical trials is a significant concern, with undetected cases likely. Central statistical monitoring offers a cost-effective method for early detection, improving overall data quality and identifying fraud missed by traditional site monitoring.

Keywords:
central statistical monitoringdata fabrication and falsificationdata frauddata quality

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Experiment Videos

Last Updated: Apr 16, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Area of Science:

  • Clinical research
  • Data integrity
  • Regulatory science

Background:

  • Recent high-profile cases highlight the issue of data fabrication and falsification in clinical trials.
  • Undetected or unreported instances of data fraud are suspected to be more prevalent than publicly known.

Purpose of the Study:

  • To review the incidence of data fraud in clinical trials.
  • To examine motivations and contributing factors behind data fraud.
  • To discuss methods for early detection of data fraud through central statistical monitoring.

Main Methods:

  • Review of existing evidence on clinical trial data fraud.
  • Analysis of prominent cases of data fabrication and falsification.
  • Discussion of central statistical monitoring as a data quality tool.

Main Results:

  • Evidence suggests data fraud occurs in clinical trials, with potential for widespread undetected cases.
  • Understanding motivations and contributing factors is crucial for prevention.
  • Central statistical monitoring can effectively detect data fraud missed by on-site methods.

Conclusions:

  • Central statistical monitoring is a valuable, cost-effective strategy for early detection of data fraud in clinical trials.
  • Implementing these monitoring procedures enhances overall data quality and reliability.
  • Proactive monitoring is essential to maintain the integrity of clinical trial data.